Caroline Bonner Selected Research

Caroline Bonner Research Topics

Disease

9	Type 2 Diabetes Mellitus (MODY) 01/2022 - 07/2012
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2023 - 07/2012
4	Hyperglycemia 01/2019 - 05/2015
3	Glycosuria 01/2019 - 05/2015
3	Insulin Resistance 01/2018 - 05/2015
2	Obesity 01/2022 - 08/2015
2	Insulinoma 01/2020 - 08/2015
2	Disseminated Intravascular Coagulation 10/2019 - 01/2017
2	Glucose Intolerance 01/2017 - 01/2016
2	Mason-Type Diabetes 06/2013 - 07/2012
2	Neuroblastoma 09/2012 - 11/2006
1	Neoplasms (Cancer) 02/2024
1	Carcinogenesis 02/2024
1	Hepatocellular Carcinoma (Hepatoma) 02/2024
1	Body Weight (Weight, Body) 01/2022
1	Septic Shock (Toxic Shock Syndrome) 10/2019
1	Shock 10/2019
1	Pancreatic Fistula (Pancreatic Fistulas) 01/2019
1	Adenocarcinoma 01/2019
1	Hyperlipidemias (Hyperlipidemia) 01/2018
1	Inflammation (Inflammations) 01/2017
1	Thrombosis (Thrombus) 01/2017
1	Weight Loss (Weight Reduction) 03/2016
1	Ovarian Neoplasms (Ovarian Cancer) 09/2015
1	Ovarian Epithelial Carcinoma 09/2015
1	Peritoneal Neoplasms 09/2015
1	Alzheimer Disease (Alzheimer's Disease) 09/2012
1	Type 3 Maturity-Onset Diabetes of the Young 11/2010
1	Necrosis 04/2010
1	Status Epilepticus (Complex Partial Status Epilepticus) 12/2008
1	Hypoxia (Hypoxemia) 11/2006

Drug/Important Bio-Agent (IBA)

5	Transcription Factors (Transcription Factor)IBA 02/2024 - 11/2006
5	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 05/2015
4	Insulin (Novolin)FDA Link 01/2023 - 05/2015
3	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2019 - 05/2015
3	Proteins (Proteins, Gene)FDA Link 06/2013 - 11/2006
2	Liraglutide FDA Link 01/2022 - 01/2019
2	Dacarbazine (DIC)FDA LinkGeneric 10/2019 - 01/2017
2	AntithrombinsIBA 10/2019 - 01/2017
2	dapagliflozinIBA 01/2019 - 05/2015
2	Glucagon (Glukagon)FDA Link 01/2019 - 05/2015
2	SodiumIBA 07/2016 - 05/2015
2	Hepatocyte Nuclear FactorsIBA 06/2013 - 11/2010
1	ElementsIBA 02/2024
1	Carrier Proteins (Binding Protein)IBA 02/2024
1	CarbohydratesIBA 02/2024
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2022
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2022
1	Glucagon-Like Peptides (Enteroglucagon)IBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	Proglucagon (Glucagon Precursors)IBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	EndotoxinsIBA 10/2019
1	ChromatinIBA 01/2017
1	Heparin (Liquaemin)FDA LinkGeneric 01/2017
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2017
1	SerpinsIBA 01/2017
1	Long Noncoding RNAIBA 01/2017
1	Sodium-Glucose Transport ProteinsIBA 07/2016
1	LDL CholesterolIBA 01/2016
1	oxidized low density lipoproteinIBA 01/2016
1	Lysine AcetyltransferasesIBA 01/2016
1	Photosensitizing Agents (Photosensitizers)IBA 09/2015
1	Folic Acid (Vitamin M)FDA LinkGeneric 09/2015
1	Hypoglycemic Agents (Hypoglycemics)IBA 05/2015
1	Blood Glucose (Blood Sugar)IBA 05/2015
1	SymportersIBA 05/2015
1	Hepatocyte Nuclear Factor 4IBA 05/2015
1	LithostathineIBA 06/2013
1	C-Reactive ProteinIBA 06/2013
1	Amyloid (Amyloid Fibrils)IBA 09/2012
1	ClusterinIBA 09/2012
1	Messenger RNA (mRNA)IBA 09/2012
1	GlucokinaseIBA 07/2012
1	Adenosine Triphosphate (ATP)IBA 04/2010
1	Glutamate Receptors (Glutamate Receptor)IBA 04/2010
1	CalciumIBA 12/2008
1	salicylhydroxamic acid (SHAM)IBA 12/2008
1	Transcription Factor CHOPIBA 11/2006
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2006

Therapy/Procedure

3	Therapeutics 10/2019 - 09/2015
2	Islets of Langerhans Transplantation 01/2023 - 01/2017
2	Transplantation 01/2017 - 05/2015
2	Gastric Bypass (Roux-en-Y Gastric Bypass) 07/2016 - 03/2016
1	Pancreatectomy 01/2019
1	Autologous Transplantation 01/2019
1	Biological Therapy 05/2015